252 related articles for article (PubMed ID: 20840749)
21. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.
Sales KJ; Maudsley S; Jabbour HN
Mol Endocrinol; 2004 Jun; 18(6):1533-45. PubMed ID: 15044590
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.
Catalano RD; Wilson MR; Boddy SC; McKinlay AT; Sales KJ; Jabbour HN
PLoS One; 2011 May; 6(5):e19209. PubMed ID: 21589857
[TBL] [Abstract][Full Text] [Related]
24. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway.
Sales KJ; Battersby S; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Dec; 89(12):6112-8. PubMed ID: 15579767
[TBL] [Abstract][Full Text] [Related]
26. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
27. Cyr61 suppresses growth of human endometrial cancer cells.
Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
[TBL] [Abstract][Full Text] [Related]
28. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
29. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
Liang S; Huang C; Jia S; Wang B
Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
[TBL] [Abstract][Full Text] [Related]
30. The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair.
Maybin JA; Battersby S; Hirani N; Nikitenko LL; Critchley HO; Jabbour HN
Endocrinology; 2011 Jul; 152(7):2845-56. PubMed ID: 21558311
[TBL] [Abstract][Full Text] [Related]
31. ADAMTS1 is a unique hypoxic early response gene expressed by endothelial cells.
Hatipoglu OF; Hirohata S; Cilek MZ; Ogawa H; Miyoshi T; Obika M; Demircan K; Shinohata R; Kusachi S; Ninomiya Y
J Biol Chem; 2009 Jun; 284(24):16325-16333. PubMed ID: 19349275
[TBL] [Abstract][Full Text] [Related]
32. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes.
Liang Y; Woodward DF; Guzman VM; Li C; Scott DF; Wang JW; Wheeler LA; Garst ME; Landsverk K; Sachs G; Krauss AH; Cornell C; Martos J; Pettit S; Fliri H
Br J Pharmacol; 2008 Jul; 154(5):1079-93. PubMed ID: 18587449
[TBL] [Abstract][Full Text] [Related]
33. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
34. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
36. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Int J Cancer; 2011 Jun; 128(11):2613-24. PubMed ID: 20715109
[TBL] [Abstract][Full Text] [Related]
37. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
38. Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis.
Obika M; Ogawa H; Takahashi K; Li J; Hatipoglu OF; Cilek MZ; Miyoshi T; Inagaki J; Ohtsuki T; Kusachi S; Ninomiya Y; Hirohata S
Cancer Sci; 2012 Oct; 103(10):1889-97. PubMed ID: 22776012
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
40. Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.
Maldonado-Pérez D; Brown P; Morgan K; Millar RP; Thompson EA; Jabbour HN
Biochim Biophys Acta; 2009 Jul; 1793(7):1315-24. PubMed ID: 19348862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
